Charles Schwab’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-289,551
| Closed | -$4.39M | – | 3256 |
|
|
2019
Q4 | $4.39M | Buy |
289,551
+5,191
| +2% | +$44.8K | ﹤0.01% | 2087 |
|
|
2019
Q3 | $1.82M | Buy |
284,360
+16,582
| +6% | +$138K | ﹤0.01% | 2408 |
|
|
2019
Q2 | $2.56M | Buy |
267,778
+47,429
| +22% | +$511K | ﹤0.01% | 2285 |
|
|
2019
Q1 | $2.99M | Buy |
220,349
+33,848
| +18% | +$282K | ﹤0.01% | 2219 |
|
|
2018
Q4 | $1.34M | Sell |
186,501
-2,524
| -1% | -$27.6K | ﹤0.01% | 2446 |
|
|
2018
Q3 | $2.06M | Buy |
189,025
+17,023
| +10% | +$172K | ﹤0.01% | 2418 |
|
|
2018
Q2 | $1.58M | Buy |
172,002
+14,872
| +9% | +$139K | ﹤0.01% | 2440 |
|
|
2018
Q1 | $1.26M | Sell |
157,130
-23,105
| -13% | -$503K | ﹤0.01% | 2453 |
|
|
2017
Q4 | $5.01M | Buy |
180,235
+30,244
| +20% | +$802K | ﹤0.01% | 1920 |
|
|
2017
Q3 | $4.05M | Buy |
149,991
+9,496
| +7% | +$248K | ﹤0.01% | 1988 |
|
|
2017
Q2 | $4.09M | Buy |
140,495
+27,259
| +24% | +$829K | ﹤0.01% | 1924 |
|
|
2017
Q1 | $3.86M | Buy |
113,236
+5,850
| +5% | +$189K | ﹤0.01% | 1913 |
|
|
2016
Q4 | $3.26M | Buy |
107,386
+4,986
| +5% | +$161K | ﹤0.01% | 1953 |
|
|
2016
Q3 | $3.46M | Buy |
102,400
+39,414
| +63% | +$1.27M | ﹤0.01% | 1863 |
|
|
2016
Q2 | $1.84M | Buy |
62,986
+14,566
| +30% | +$402K | ﹤0.01% | 2111 |
|
|
2016
Q1 | $1M | Buy |
48,420
+969
| +2% | +$23.8K | ﹤0.01% | 2350 |
|
|
2015
Q4 | $1.64M | Sell |
47,451
-85
| -0.2% | -$2.44K | ﹤0.01% | 2181 |
|
|
2015
Q3 | $1.11M | Buy |
47,536
+29,336
| +161% | +$713K | ﹤0.01% | 2354 |
|
|
2015
Q2 | $320K | Buy |
+18,200
| New | +$281K | ﹤0.01% | 2852 |
|
Charles Schwab's DERM Position: Q1 2020 in Review
Charles Schwab sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 289,551 shares — an estimated $4.39M sold.
Charles Schwab first reported a position in DERM in Q2 2015 and held it in 19 quarters. The position peaked at $5.01M in Q4 2017. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- Charles Schwab reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- Charles Schwab sold 289,551 Dermira, Inc. shares in Q1 2020, an estimated $4.39M.
- Charles Schwab first reported a position in Dermira, Inc. in Q2 2015 and held it in 19 quarters.
- Charles Schwab's Dermira, Inc. position peaked at $5.01M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on Charles Schwab's 13F filing for Q1 2020, filed 15 May 2020.